Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2014	Jun. 30, 2014
Current assets:
Cash	$ 503
Accounts receivable, net	4,284	$ 11,487
Inventory, net	67,994	$ 69,319
Other current assets	167,083
Total current assets	239,864	$ 80,806
Other assets	10,500	10,500
Total assets	250,364	91,306
Current liabilities:
Accounts payable and accrued liabilities	270,126	1,042,766
Accrued interest	141,125	206,386
Accrued compensation and personnel related payables	$ 373,455	373,455
Production line of credit		324,000
Derivative liabilities	$ 358,000	228,237
Total current liabilities	1,142,706	2,174,844
Long term liabilities
Convertible notes payable, net	425,000	525,000
Notes payable due to shareholder	86,000	186,000
Note payable due to bank	25,982	25,982
Total long term liabilities	536,982	736,982
Total liabilities	1,679,688	$ 2,911,826
Stockholders' deficiency:
Common Stock Payable	$ 837,674
Preferred stock ($0.001 par value, 10,000,000 shares authorized, none issued and outstanding)
Common stock ($0.001 par value, 300,000,000 shares authorized, 38,770,473 shares issued and outstanding at September 30, 2014; 10,583,555 at June 30, 2014)	$ 38,771	$ 10,539
Additional paid-in capital	14,715,574	8,329,959
Accumulated deficit	(17,021,343)	(11,161,019)
Total stockholders' deficiency	(1,429,324)	(2,820,520)
Total liabilities and stockholder's deficiency	$ 250,364	$ 91,306